Fig. 1From: MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancerExpression and predictive performance of miR-3168, miR-6125, and miR-4718. a. Expression of miR-3168, miR-6125, and miR-4718 in the nephrotoxicity and non-nephrotoxicity group before and five days (D5) after cisplatin administration. b. Receiver operating characteristic curve (ROC) of baseline miRNAs expression adjusted for age and gender. c. Details of the area under the curve (AUC), cutoff, sensitivity, and specificity of miRNAs expression before cisplatin administration as prognostic markers of cisplatin-induced nephrotoxicityBack to article page